Scrofula Caused by Multidrug-Resistant Tuberculosis
  • Bárbara Pedro
    Cerviço de Medicina II, Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal
  • Liliana Alves
    Serviço de Infecciologia, Hospital Garcia de Orta, Almada, Portugal
  • Rita Magano
    Serviço de Infecciologia, Hospital Garcia de Orta, Almada, Portugal
  • Tomás Nunes
    Serviço de Infecciologia, Hospital Garcia de Orta, Almada, Portugal
  • Nuno Marques
    Serviço de Infecciologia, Hospital Garcia de Orta, Almada, Portugal

Keywords

Mycobacterium tuberculosis, lymphadenitis, scrofula, multidrug-resistant tuberculosis

Abstract

Tuberculosis (TB) is one of the top 10 causes of death worldwide. Multidrug-resistant tuberculosis (MDR-TB) occurs when at the minimum there is resistance to isoniazid and rifampin. Prevention of new infections of Mycobacterium tuberculosis and progression to TB disease is critical to reduce the burden and mortality of this disease. We present the case of a 73-year-old human immunodeficiency virus (HIV)-negative female who presented with cervical lymphadenopathy and who was diagnosed with MDR-TB.

VIEW THE ENTIRE ARTICLE

References

  • Global tuberculosis report 2018. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. Available online: https://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf (accessed August 30, 2019).

  • Tuberculose em Portugal | Desafios e Estratégias 2018. Programa Nacional para a Tuberculose. Available online: https://www.dgs.pt/documentos-e-publicacoes/tuberculose-em-portugal-desafios-e-estrategias-2018-.aspx (accessed August 30, 2019).

  • Fontanilla JM, Barnes A, von Reyn CF. Current diagnosis and management of peripheral tuberculous lymphadenitis. Clin Infect Dis 2011;53:555–562.

  • Ogundipe T, Otolorin A, Ogundipe F, Sran G, Abbas G, Filani O. Multidrug-resistant tuberculosis lymphadenitis as the initial presentation of secondary multidrug-resistant tuberculosis: a case report. Cureus 2018;10(3):e2363.

  • WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO. Available online: https://apps.who.int/iris/bitstream/handle/10665/311389/9789241550529-eng.pdf (accessed August 30, 2019).

    • Views: 907
    HTML downloads: 686
    PDF downloads: 408

    Published: 2020-01-02
    Issue: 2020: Vol 7 No 1 (view)

    How to cite:
    1.
    Pedro B, Alves L, Magano R, Nunes T, Marques N. Scrofula Caused by Multidrug-Resistant Tuberculosis. EJCRIM 2020;7 doi:10.12890/2020_001390.